恩帕吉菲
医学
肾功能
危险系数
内科学
心力衰竭
心脏病学
射血分数保留的心力衰竭
置信区间
射血分数
安慰剂
人口
泌尿科
糖尿病
内分泌学
2型糖尿病
病理
替代医学
环境卫生
作者
Tripti Rastogi,João Pedro Ferreira,Javed Butler,Bettina Kraus,Michaela Mattheus,Martina Brueckmann,Gerasimos Filippatos,Christoph Wanner,Stuart Pocock,Milton Packer,Stefan D. Anker,Faı̈ez Zannad
摘要
Renal function (estimated glomerular filtration rate [eGFR]) changes early after the introduction of empagliflozin have not been described in heart failure with preserved ejection fraction (HFpEF). The aim of this study was to describe early eGFR changes, assess its determinants and its clinical impact on cardiovascular and renal outcomes in patients with HFpEF enrolled in EMPEROR-Preserved.
科研通智能强力驱动
Strongly Powered by AbleSci AI